Key Finding
Acceptance and commitment therapy for general chronic pain, and fluoxetine with web-based psychotherapy for fibromyalgia showed the most robust effects for treating depression in chronic pain patients, though no single intervention demonstrated superiority across all pain types.
Researchers conducted a comprehensive review examining what treatments work best for depression in people living with chronic pain. They analyzed 83 reviews containing 182 separate studies, looking at various interventions including psychological therapies, medications, exercise, and complementary approaches like music therapy. The study found that different treatments worked better for different types of chronic pain. Acceptance and commitment therapy showed strong results for general chronic pain, while fluoxetine (an antidepressant) and web-based psychotherapy were most effective for fibromyalgia patients. Exercise helped arthritis patients, and specific medications worked for nerve pain. Music therapy also showed promising results for general chronic pain sufferers. Importantly, no single treatment proved superior across all pain conditions, suggesting that personalized approaches are necessary. The researchers noted that acupuncture is a commonly used intervention for chronic pain, but they found insufficient high-quality research to determine its effectiveness specifically for treating depression in chronic pain patients. This doesn't mean acupuncture doesn't work—rather, more rigorous studies are needed. When considering treatment options, the authors emphasize that factors beyond effectiveness matter too, including accessibility, safety, cost, and patient preference. For people with chronic pain experiencing depression, this review suggests multiple treatment options exist, and choosing the right approach should involve discussing individual circumstances, preferences, and the specific type of pain condition with healthcare providers. If considering acupuncture as part of your treatment plan, seek a licensed or certified acupuncturist with experience treating chronic pain.
This systematic review of meta-analyses examined interventions for depressive symptoms in chronic pain populations, searching seven databases through September 2020. Eighty-three reviews were included, encompassing 182 meta-analyses. Most studies investigated fibromyalgia or mixed chronic pain populations, with psychological interventions most frequently evaluated. Results were analyzed using standardized mean differences with 95% confidence intervals. Acceptance and commitment therapy for general chronic pain, and fluoxetine plus web-based psychotherapy for fibromyalgia demonstrated the most robust effects suitable for clinical implementation. Exercise for arthritis, pharmacotherapy for neuropathic pain, self-regulatory psychotherapy for axial pain, and music therapy for general chronic pain showed large significant effects, though derived from low-quality reviews. No intervention type showed clear superiority across multiple pain populations. The authors specifically identified acupuncture, along with opioids and anti-inflammatories, as requiring further effectiveness research despite common clinical use. Clinical decision-making should incorporate accessibility, safety, cost, patient preference, and efficacy for non-depressive outcomes beyond the depression-specific findings reported.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 6-week integrative Korean medicine treatment centered on high-dose Angelica gigas produced clinically significant improvements in pain, function, and quality of life in a patient with 10-year treatment-refractory fibromyalgia unresponsive to opioid therapy.
📌 SSRIs significantly reduced pain and depression in fibromyalgia compared to placebo, but showed no significant advantage over non-pharmacological interventions including acupuncture for treating depression.
📌 Left-sided auricular vagus nerve stimulation reduced pro-inflammatory cytokines and increased anti-inflammatory markers and BDNF in women with fibromyalgia, despite not producing superior pain relief compared to sham treatment.